Global Commercial Scaling
Client: Union Springs Pharmaceuticals
Category: Commercialization
The principals of Allura Global managed the launch, approval, sales, marketing, and distribution of the MyClyns First Response Personal Protection Spray. MyClyns was a Class IIa medical device cleared in the U.S., European Union, and Canada, used for the cleansing and debridement of pathogens from mucous membranes.
Manufacturing and Logistics
Regulatory Affairs
Sales Program
Company Acquisition Oversight
The team managing MyClyns worked to secure product clearance in 22 countries, paving the way for global distribution and sales. Central to MyClyns’ success was a product portfolio that relied on securing major endorsements from first responder associations and key opinion leaders (KOLs), followed by a focus on field-based proactive pathogen response training. Ultimately, the company and its product portfolio were acquired in 2017 by a publicly traded healthcare company.
